References
- Ogawa Y, Yamamoto M, Okada H, Yashiki T, Shimamoto T. (1988). A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem Pharm Bull, 36:1095–1103.
- Ogawa Y, Yamamoto M, Takada S, Okada H, Shimamoto T. (1988). Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. Chem Pharm Bull, 36:1502–1507.
- Ito F, Makino K. (2004). Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres. Colloids Surf B Biointerfaces, 39:17–21.
- Ito F, Fujimori H, Honnami H, Kawakami H, Kanamura K, Makino K. (2008). Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique. Colloids Surf B Biointerfaces, 66:65–70.
- Ito F, Honnami H, Kawakami H, Kanamura K, Makino K. (2008). Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (shirasu porous glass) membrane emulsification technique. Colloids Surf B Biointerfaces, 67:20–25.
- Ito F, Fujimori H, Honnami H, Kawakami H, Kanamura K, Makino K. (2009). Study of types and mixture ratio of organic solvent used to dissolve polymers for preparation of drug-containing PLGA microspheres. Euro Polymer J, 45:658–667.
- Ito F, Fujimori H, Honnami H, Kawakami H, Kanamura K, Makino K. (2010). Control of drug loading efficiency and drug release behavior in preparation of hydrophilic-drug-containing monodisperse PLGA microspheres. J Mater Sci Mater Med, 21:1563–1571.
- Rajeev AJ. (2000). The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 21:2475–2490.
- Hoppe U, Bergemann J, Diembeck W, Ennen J, Gohla S, Harris I et al. (1999). Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors, 9:371–378.
- Ankola DD, Viswanad B, Bhardwaj V, Ramarao P, Kumar MN. (2007). Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? Eur J Pharm Biopharm, 67:361–369.
- Nehilla BJ, Bergkvist M, Popat KC, Desai TA. (2008). Purified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles. Int J Pharm, 348:107–114.
- Nehilla BJ, Allen PG, Desai TA. (2008). Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles. ACS Nano, 2:538–544.
- Yogeshvar NK, Ararti N, James G, Richard HG. (2004) Iontophoretic drug delivery. Adv Drug Delivery Rev, 56:619–658.
- Makino K, Nakajima T, Shikamura M, Ito F, Ando S, Kochi C et al. (2004). Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloids Surf B Biointerfaces, 36:35–42.
- Faisant N, Akiki J, Siepmann F, Benoit JP, Siepmann J. (2006). Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Int J Pharm, 314:189–197.
- Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. (2008). PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharm, 349:249–255.
- Klose D, Siepmann F, Willart JF, Descamps M, Siepmann J. (2010). Drug release from PLGA-based microparticles: effects of the “microparticle:bulk fluid” ratio. Int J Pharm, 383:123–131.
- Ito F, Fujimori H, Makino K. (2007). Incorporation of water-soluble drugs in PLGA microspheres. Colloids Surf B Biointerfaces, 54:173–178.